Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher's Precision ID NGS System for Forensic Analysis

Thermo Fisher Scientific has launched its Precision ID next-generation sequencing system. The system comprises five distinct Precision ID panels to suit the varying needs of forensic casework: The Precision ID GlobalFiler NGS STR panel, which analyzes a total of 33 targets, including the expanded CODIS loci; the Precision ID mtDNA Whole Genome panel, which uses an innovative small-target approach to obtain optimal results from highly compromised and degraded samples, such as hair shafts, teeth, and bones; the Precision ID mtDNA Control Region panel, which is similar to the Whole Genome panel but targets the 1.2kb control region and covers HV-I, II, and III; the Precision ID Identity Panel, which is composed of 124 SNP markers, providing discrimination of individuals similar to STR genotype match probabilities used by forensic analysts; and the Precision ID Ancestry Panel, which is composed of 165 SNP markers that provide biogeographic ancestry information to guide the investigation process.

Each panel is designed to work with the Ion Chef System for automated library and template preparation and the Ion S5 and Ion S5 XL systems, and the two chip formats also enable multiple panels to be sequenced in a single run, the company said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.